P21WAF1 is involved in interferon-β- induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer

Molecules and Cells

Volumn 30, Issue 4, 2010, Pages 327-333

  Lee, Ji Hae ^a   Lee, Seung Yeul ^a   Lee, Je Ho ^b   Lee, Seung Hoon ^a  

^a Yongin University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

hTERT; interferon (IFN ); ovarian cancer; p21 WAF1 CIP1; telomerase

Indexed keywords

BETA INTERFERON; CYCLIN DEPENDENT KINASE INHIBITOR 1; MESSENGER RNA; PROTEIN P21; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; ENZYME ACTIVITY; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON-BETA; MICE; MICE, MUTANT STRAINS; OVARIAN NEOPLASMS; OVARY; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

MURINAE;

EID: 78650509738     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-010-0131-y     Document Type: Article

References (52)

1. M. Akiyama S. Iwase J. Horiguchi-Yamada S. Saito Y. Furukawa O. Yamada H. Mizoguchi T. Ohno H. Yamada 1999 Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells Cancer Lett. 142 23 30 1:CAS:528: DyaK1MXjs1SjtL4%3D 10.1016/S0304-3835(99)00109-3 10424777 (Pubitemid 29281563)
2. M.A. Anttila V.M. Kosma J. Hongxiu J. Puolakka M. Juhola S. Saarikoski K. Syrjänen 1999 p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer Br. J. Cancer 79 1870 1878 1:STN:280:DyaK1M3itFWnug%3D%3D 10.1038/sj.bjc.6690298 10206307 (Pubitemid 29132318)
3. V.L. Bae-Jump C. Zhou P.A. Gehrig Y.E. Whang J.F. Boggess 2006 Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest Gynecol. Oncol. 100 487 494 1:CAS:528:DC%2BD28XhsFKrtrk%3D 10.1016/j.ygyno.2005. 08.053 16249016 (Pubitemid 43246863)
4. A. Bali P.M. O'Brien L.S. Edwards R.L. Sutherland N.F. Hacker S.M. Henshall 2004 Cyclin D1, p53, and p21Waf1/ Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer Clin. Cancer Res. 10 5167 5177 (Pubitemid 39099792)
5. K.J. Buchkovich C.W. Greider 1996 Telomerase regulation during entry into the cell cycle in normal human T cells Mol. Cell. Biol. 16 1443 1454 (Pubitemid 26304205)
6. L.G. Buchynska I.P. Nesina N.P. Yurchenko O.O. Bilyk V.N. Grinkevych V.S. Svintitsky 2007 Expression of p53, p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors Exp. Oncol. 29 49 53 1:CAS:528:DC%2BD2sXlslWhu78%3D 17431389
7. M. Chawla-Sarkar D.W. Leaman E.C. Borden 2001 Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines Clin. Cancer Res. 7 1821 1831 1:CAS:528:DC%2BD3MXltV2hsLY%3D 11410525 (Pubitemid 32708654)
8. C.M. Counter H.W. Hirte S. Bacchetti C.B. Harley 1994 Telomerase activity in human ovarian carcinoma Proc. Natl. Acad. Sci. USA 91 2900 2904 1:CAS:528:DyaK2cXivFGntL4%3D 10.1073/pnas.91.8.2900 8159676 (Pubitemid 24130141)
9. D.L. Crowe D.C. Nguyen 2001 Rb and E2F-1 regulate telomerase activity in human cancer cells Biochim. Biophys. Acta 1518 1 6 1:CAS:528: DC%2BD3MXitVOlu70%3D 11267653 (Pubitemid 32232270)
10. B. Damdinsuren H. Nagano M. Sakon M. Kondo T. Yamamoto K. Umeshita K. Dono S. Nakamori M. Monden 2003 Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs Ann. Surg. Oncol. 10 1184 1190 10.1245/ASO.2003.03.010 14654475 (Pubitemid 40486814)
11. E. De Maeyer J. De Maeyer-Guignard 1998 Type I interferons Int. Rev. Immunol. 17 53 73 9914943 (Pubitemid 29014545)
12. L.P. Deiss E. Feinstein H. Berissi O. Cohen A. Kimchi 1995 Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon- induced cell death Genes Dev. 9 15 30 1:CAS:528:DyaK2MXjtFWqtL0%3D 10.1101/gad.9.1.15 7828849
13. W.S. el-Deiry T. Tokino V.E. Velculescu D.B. Levy R. Parsons J.M. Trent D. Lin W.E. Mercer K.W. Kinzler B. Vogelstein 1993 WAF1, a potential mediator of p53 tumor suppression Cell 75 817 825 1:CAS:528:DyaK2cXpslGguw%3D%3D 10.1016/0092-8674(93)90500-P 8242752 (Pubitemid 23346378)
14. V. Giandomenico G. Vaccari G. Fiorucci Z. Percario S. Vannuchi P. Matarrese W. Malorni G. Romeo G.R. Affabris 1998 Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21 Eur. Cytokine Netw. 9 619 631 1:CAS:528:DyaK1MXnvFalsA%3D%3D 9889406 (Pubitemid 29033929)
15. W.C. Hahn S.A. Stewart M.W. Brooks S.G. York E. Eaton A. Kurachi R.L. Beijersbergen J.H. Knoll M. Meyerson R.A. Weinberg 1999 Inhibition of telomerase limits the growth of human cancer cells Nat. Med. 5 1164 1170 1:CAS:528:DyaK1MXms1Wktrk%3D 10.1038/13495 10502820 (Pubitemid 29474421)
16. S.K. Hendren I. Prabakaran D.G. Buerk G. Karakousis M. Feldman F. Spitz C. Menon D.L. Fraker 2004 Interferon- beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis Surgery 135 427 436 10.1016/j.surg.2003.08.015 15041967 (Pubitemid 38453498)
17. R. Henriksen P. Strang E. Wilander T. Bäckström B. Tribukait K. Oberg 1994 p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry Gynecol. Oncol. 53 301 306 1:STN:280:DyaK2c3ms1Wrtg%3D%3D 10.1006/gyno.1994.1138 8206402 (Pubitemid 24187857)
18. X. Hu J. Bies L. Wolff 2005 Interferon beta increases c- Myc proteolysis in mouse monocyte/macrophage leukemia cells Leuk. Res. 29 1307 1314 1:CAS:528:DC%2BD2MXhtVWgs73I 10.1016/j.leukres.2005.04.002 15939469 (Pubitemid 41297643)
19. Y. Ichikawa M. Nishida H. Suzuki S. Yoshida H. Tsunoda T. Kubo K. Uchida M. Miwa 1994 Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors Cancer Res. 54 33 35 1:CAS:528:DyaK2cXhtVemsbY%3D 8261457 (Pubitemid 24042083)
20. R.J. Jackson R.W. Engelman D. Coppola A.B. Cantor W. Wharton W.J. Pledger 2003 P21Cip1 Nullizygosity increases tumor metastasis in Irradiated mice Cancer Res. 63 3021 3025 1:CAS:528:DC%2BD3sXks1eit7k%3D 12810620 (Pubitemid 36735844)
21. A. Jemal R. Siegel E. Ward T. Murray J. Xu C. Smigal M.J. Thun 2006 Cancer statistics CA Cancer J. Clin. 56 106 130 10.3322/canjclin.56.2.106 16514137
22. R. Kar S. Sen A. Singh H. Sharma S. Kumar S.D. Gupta N. Singh 2007 Role of apoptotic regulators in human epithelial ovarian cancer Cancer Biol. Ther. 6 1101 1105 1:CAS:528:DC%2BD2sXhsVWksrfK 10.4161/cbt.6.7.4329 17611399 (Pubitemid 351574963)
23. T. Katayama Y. Saitoh C. Nemoto T. Hirama T. Isosu M. Murakawa 2007 Effects of olprinone on neuromuscular blockade caused by vecuronium Fukushima J. Med. Sci. 53 61 69 1:CAS:528:DC%2BD1cXkt1yltLw%3D 18402286
24. S. Kondo Y. Tanaka Y. Kondo M. Hitomi G.H. Barnett Y. Ishizaka J. Liu T. Haqqi A. Nishiyama B. Villeponteau 1998 Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation FASEB J. 12 801 811 1:CAS:528:DyaK1cXktlCku7o%3D 9657520 (Pubitemid 28294670)
25. S. Kyo T. Kanaya M. Takakura M. Tanaka A. Yamashita H. Inoue M. Inoue 1999 Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors Int. J. Cancer 80 804 809 1:CAS:528:DyaK1MXhvVGgtL4%3D 10.1002/(SICI)1097-0215(19990315)80:6<804::AID-IJC2>3.0.CO;2-B 10074910 (Pubitemid 29108852)
26. S. Kyo M. Takakura T. Taira T. Kanaya H. Itoh M. Yutsudo H. Ariga M. Inoue 2000 Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) Nucleic Acids Res. 28 669 677 1:CAS:528:DC%2BD3cXhtVSnsbc%3D 10.1093/nar/28.3.669 10637317 (Pubitemid 30068249)
27. S.H. Lee J.W. Kim H.W. Lee Y.S. Cho S.H. Oh Y.J. Kim C.H. Jung W. Zhang J.H. Lee 2003 Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression Oncogene 22 381 391 1:CAS:528:DC%2BD3sXlsV2luw%3D%3D 10.1038/sj.onc.1206133 12545159 (Pubitemid 36194334)
28. S.H. Lee J.W. Kim S.H. Oh Y.J. Kim S.B. Rho K. Park K.L. Park J.H. Lee 2005 IFN-gamma/IRF-1-induced p27kip1 down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer FEBS Lett. 579 1027 1033 1:CAS:528:DC%2BD2MXhtlOgurg%3D 10.1016/j.febslet.2005.01.005 15710386 (Pubitemid 40248664)
29. D.J. Lindner E.C. Borden 1997 Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis Int. J. Cancer. 71 456 461 1:CAS:528:DyaK2sXjtleqs70%3D 10.1002/(SICI)1097-0215(19970502)71:3<456::AID- IJC25>3.0.CO;2-C 9139884 (Pubitemid 27224313)
30. J.P. Maciejewski C. Selleri T. Sato H.J. Cho L.K. Keefee C.F. Nathan N.S. Young 1995 Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha J. Clin. Invest. 96 1085 1092 1:CAS:528:DyaK2MXnsVans7g%3D 10.1172/JCI118094 7543491
31. H. Meden D. Marx W. Rath 1994 Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancy Int. J. Gynecol. Patho. 13 45 53 1:STN:280:DyaK2c7ls1Gqsw%3D%3D 10.1097/00004347-199401000-00006 (Pubitemid 24101439)
32. M. Meyerson C.M. Counter E.N. Eaton L.W. Ellisen P. Steiner S.D. Caddle L. Ziaugra R.L. Beijersbergen M.J. Davidoff Q. Liu 1997 hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization Cell 90 785 795 1:CAS:528:DyaK2sXlvFKmurg%3D 10.1016/S0092-8674(00)80538-3 9288757 (Pubitemid 27357969)
33. B.H. Morrison J.A. Bauer D.V. Kalvakolanu D.J. Lindner 2001 Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells J. Biol. Chem. 276 24965 24970 1:CAS:528:DC%2BD3MXlt1agtLc%3D 10.1074/jbc.M101161200 11337497 (Pubitemid 37412970)
34. B.H. Morrison Z. Tang B.S. Jacobs J.A. Bauer D.J. Lindner 2005 Apo2L/TRAIL induction and nuclear translocation of inositol hexakisphosphate kinase 2 during IFN-beta-induced apoptosis in ovarian carcinoma Biochem. J. 385 595 603 1:CAS:528:DC%2BD2MXhvVCluw%3D%3D 10.1042/BJ20040971 15634191 (Pubitemid 40165094)
35. T.M. Nakamura G.B. Morin K.B. Chapman S.L. Weinrich W.H. Andrews J. Lingner C.B. Harley T.R. Cech 1997 Telomerase catalytic subunit homologs from fission yeast and human Science 277 955 959 1:CAS:528:DyaK2sXltlCqu7s%3D 10.1126/science.277.5328.955 9252327 (Pubitemid 27366681)
36. M. Odaka D.H. Sterman R. Wiewrodt Y. Zhang M. Kiefer K.M. Amin G. Gao J.M. Wilson J. Barsoum L.R. Kaiser 2001 Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity Cancer Res. 61 6201 6212 1:CAS:528:DC%2BD3MXmt12ktbk%3D 11507073 (Pubitemid 32762558)
37. M. Odaka R. Wiewrodt P. DeLong T. Tanaka Y. Zhang L. Kaiser S. Albelda 2002 Analysis of the immunologic response generated by Ad.IFN-beta during successful intraperitoneal tumor gene therapy Mol. Ther. 6 210 218 1:CAS:528:DC%2BD38XmtFaqsrc%3D 10.1006/mthe.2002.0656 12161187 (Pubitemid 36336128)
38. S.T. Oh S. Kyo L.A. Laimins 2001 Telomerase activation by human papillimavirus type 16E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites J. Virol. 75 5559 5566 1:CAS:528:DC%2BD3MXjvFyrsb4%3D 10.1128/JVI.75.12.5559-5566.2001 11356963 (Pubitemid 32488149)
39. J. Sanceau J. Hiscott O. Delattre J. Wietzerbin 2000 IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7 Oncogene 19 3372 3383 1:CAS:528:DC%2BD3cXlsFOqtb4%3D 10.1038/sj.onc.1203670 10918594 (Pubitemid 30479332)
40. I. Shats M. Milyavsky X. Tang P. Stambolsky N. Erez R. Brosh I. Kogan I. Braunstein M. Tzukerman D. Ginsberg 2004 p53-dependent down-regulation of telomerase is mediated by p21waf1 J. Biol. Chem. 279 50976 50985 1:CAS:528:DC%2BD2cXhtVaqsr7E 10.1074/jbc.M402502200 15371422 (Pubitemid 40017838)
41. J.W. Shay S. Bacchetti 1997 A survey of telomerase activity in human cancer Eur. J. Cancer 33 787 791 1:STN:280:DyaK2svis12qug%3D%3D 10.1016/S0959-8049(97)00062-2 9282118 (Pubitemid 27239490)
42. M. Shiratsuchi K. Muta T. Umemura J. Nishimura H. Nawata M. Kozuru 1999 Telomerase activity in myeloma cells is closely related to cell cycle status, but not to apoptotic signals induced by interferon-alpha Lymphoma 34 349 359 1:CAS:528:DC%2BD3MXltFarsrY%3D (Pubitemid 29385178)
43. M. Takakura S. Kyo T. Kanaya M. Tanaka M. Inoue 1998 Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer Cancer Res. 58 1558 1561 1:CAS:528:DyaK1cXit1eksLc%3D 9537264 (Pubitemid 28193624)
44. M.N. Varras G. Sourvinos E. Diakomanolis E. Koumantakis G.A. Flouris J. Lekka-Katsouli S. Michalas D.A. Spandidos 1999 Detection and clinical correlations of ras gene mutations in human ovarian tumors Oncology 56 89 96 1:CAS:528:DyaK1MXhsFantr4%3D 10.1159/000011946 9949292 (Pubitemid 29080616)
45. M. Wan W.Z. Li B.D. Duggan J.C. Felix Y. Zhao L. Dubeau 1997 Telomerase activity in benign and malignant epithelial ovarian tumors J. Natl. Cancer Inst. 89 437 441 1:STN:280:DyaK2s3ivVWhtQ%3D%3D 10.1093/jnci/89.6.437 9091645 (Pubitemid 27136735)
46. J. Wang L.Y. Xie S. Allan D. Beach G.J. Hannon 1998 Myc activates telomerase Genes Dev. 12 1769 1774 1:CAS:528:DyaK1cXktl2isbk%3D 10.1101/gad.12.12.1769 9637678 (Pubitemid 28304329)
47. J. Won J. Yim T.K. Kim 2002 Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells FASEB. J. 16 1943 1945 1:CAS:528:DC%2BD38Xps1Kqurg%3D 12368233
48. K.J. Wu C. Brandori M. Amacker N. Simon-Vermont A. Polack J. Lingner R. Dalla-Favera 1999 Direct activation of TERT transcription by c-MYC Nat. Genet. 21 220 224 1:CAS:528:DyaK1MXpsVCrsg%3D%3D 10.1038/6010 9988278 (Pubitemid 29070372)
49. D. Xu S. Erickson M. Szeps A. Gruber O. Sangfelt S. Einhorn P. Pisa D. Grander 2000 Interferon alpha down-regulates telomerase reverse transcriptase and telomerase activity in human malignant and nonmalignant hematopoietic cells Blood 96 4313 4318 1:CAS:528:DC%2BD3cXosl2htLs%3D 11110707
50. D. Xu Q. Wang A. Gruber Z. Chen A. Zaid G. Selivanova C. Peterson K.G. Wiman P. Pisa 2000 Down regulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells Oncogene 29 5123 5133 10.1038/sj.onc.1203890
51. X. Zhang V. Mar W. Zhou L. Harrington M.O. Robinson 1999 Telomere shortening and apoptosis in telomerase-inhibited human tumor cells Genes Dev. 13 2388 2399 1:CAS:528:DyaK1MXmsVCgsbY%3D 10.1101/gad.13.18.2388 10500096 (Pubitemid 29453610)
52. X. Zhu R. Kumar M. Mandal N. Sharma H.W. Sharma U. Dhingra J.A. Sokoloski R. Hsiao R. Narayanan 1996 Cell cycle dependent modulation of telomerase activity in tumor cells Proc. Natl. Acad. Sci. USA 93 6091 6095 1:CAS:528:DyaK28Xjs1Ojtrc%3D 10.1073/pnas.93.12.6091 8650224 (Pubitemid 26190808)